Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Free Subscription


1 Acta Haematol
2 Am J Hematol
2 Ann Hematol
1 Biochem Biophys Res Commun
3 Blood
1 BMC Cancer
2 Bone Marrow Transplant
1 Cancer Chemother Pharmacol
2 Cancer Lett
3 Leuk Lymphoma
1 Leuk Res
2 Leukemia
1 Oncol Rep
1 PLoS One
1 Proc Natl Acad Sci U S A

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Acta Haematol

  1. DAMPMANN M, Flossdorf S, Keyl J, Reinhardt HC, et al
    Single-center experience of patients with plasma cell leukemia in the era of new therapeutics.
    Acta Haematol. 2024 May 19. doi: 10.1159/000539223.
    PubMed         Abstract available

    Am J Hematol

  2. DEVILLIER R, Galimard JE, Blaise D, Raiola AM, et al
    Peripheral blood stem cell versus bone marrow graft for patients >/=60 years undergoing reduced intensity conditioning haploidentical transplantation for acute myeloid leukemia in complete remission: An analysis of the Acute Leukemia Working Party of
    Am J Hematol. 2024 May 23. doi: 10.1002/ajh.27343.
    PubMed         Abstract available

  3. KOCKEROLS C, Valk PJM, Dulucq S, Nicolini FE, et al
    BCR::ABL1 digital PCR for treatment-free remission prediction in chronic myeloid leukemia patients: An individual participant data meta-analysis.
    Am J Hematol. 2024 May 20. doi: 10.1002/ajh.27359.

    Ann Hematol

  4. BRAUN A, Otoukesh S, Tinajero J, Marcucci G, et al
    Blinatumomab-induced macrophage activating syndrome (MAS) in adult with B-cell acute lymphoblastic leukemia (B-ALL).
    Ann Hematol. 2024 May 24. doi: 10.1007/s00277-024-05795.
    PubMed         Abstract available

  5. IOVENE FR, Santinelli E, Armiento D, Sarlo C, et al
    Acute myeloid leukemia with paraneoplastic pemphigus successfully treated with a personalized antileukemic and immunosuppressive strategy.
    Ann Hematol. 2024 May 23. doi: 10.1007/s00277-024-05804.
    PubMed         Abstract available

    Biochem Biophys Res Commun

  6. ZHANG S, Lou S, Bian W, Liu J, et al
    Selective eradication of venetoclax-resistant monocytic acute myeloid leukemia with iron oxide nanozymes.
    Biochem Biophys Res Commun. 2024;719:150117.
    PubMed         Abstract available


  7. SAWYER EM, Kraft AS
    SMACing down relapsed T-ALL.
    Blood. 2024;143:2116-2117.

  8. MAZZIOTTA F, Biavati L, Rimando JC, Rutella S, et al
    CD8+ T-cell Differentiation and Dysfunction Inform Treatment Response in Acute Myeloid Leukemia.
    Blood. 2024 May 22:blood.2023021680. doi: 10.1182/blood.2023021680.
    PubMed         Abstract available

  9. LEWIS RI, Vom Stein AF, Hallek MJ
    Targeting the tumor microenvironment for treating double refractory chronic lymphocytic leukemia.
    Blood. 2024 May 22:blood.2023022861. doi: 10.1182/blood.2023022861.
    PubMed         Abstract available

    BMC Cancer

  10. MAMO W, Moges A, Yesuf SA, Mohamedsaid A, et al
    Treatment outcomes of pediatrics acute myeloid leukemia (AML) and associated factors in the country's tertiary referral hospital, Ethiopia.
    BMC Cancer. 2024;24:640.
    PubMed         Abstract available

    Bone Marrow Transplant

  11. GANZEL C, Yating W, Roopcharan K, Sun Z, et al
    Shorter long-term post-transplant life expectancy may be due to prior chemotherapy for the underlying disease: analysis of 3012 patients with acute myeloid leukemia enrolled on 9 consecutive ECOG-ACRIN trials.
    Bone Marrow Transplant. 2024 May 22. doi: 10.1038/s41409-024-02308.
    PubMed         Abstract available

  12. TOLOSA-RIDAO C, Suarez-Lledo M, Jimenez-Vicente C, Cortes-Bullich A, et al
    Allogeneic hematopoietic cell transplantation with sequential conditioning regimen in relapsed refractory acute myeloid leukemia.
    Bone Marrow Transplant. 2024 May 22. doi: 10.1038/s41409-024-02310.

    Cancer Chemother Pharmacol

  13. KOBAYASHI T, Sato H, Miura M, Fukushi Y, et al
    Overexposure to venetoclax is associated with prolonged-duration of neutropenia during venetoclax and azacitidine therapy in Japanese patients with acute myeloid leukemia.
    Cancer Chemother Pharmacol. 2024 May 23. doi: 10.1007/s00280-024-04673.
    PubMed         Abstract available

    Cancer Lett

  14. XU M, Li S
    The opportunities and challenges of using PD-1/PD-L1 inhibitors for leukemia treatment.
    Cancer Lett. 2024;593:216969.
    PubMed         Abstract available

  15. WANG D, He J, Liu S, Zhang H, et al
    Anlotinib synergizes with venetoclax to induce mitotic catastrophe in acute myeloid leukemia.
    Cancer Lett. 2024 May 17:216970. doi: 10.1016/j.canlet.2024.216970.
    PubMed         Abstract available

    Leuk Lymphoma

  16. MINNEMA MC, Yin X, Davi R, Keeping S, et al
    Outcomes of patients aged >/=26 years with relapsed or refractory B-cell acute lymphoblastic leukemia in ZUMA-3 and historical trials.
    Leuk Lymphoma. 2024 May 24:1-10. doi: 10.1080/10428194.2024.2353877.
    PubMed         Abstract available

  17. BELDZINSKA-GADEK K, Zarzycka E, Pastuszak K, Borman K, et al
    Immune escape of B-cell lymphoblastic leukemic cells through a lineage switch to acute myeloid leukemia.
    Leuk Lymphoma. 2024 May 22:1-11. doi: 10.1080/10428194.2024.2351194.
    PubMed         Abstract available

  18. ZHENG Y, Li J, Wen H, Weng K, et al
    Experience in improving treatment outcomes for childhood acute lymphoblastic leukemia: real-world results for a province in China, 2011-2020.
    Leuk Lymphoma. 2024 May 20:1-11. doi: 10.1080/10428194.2024.2350665.
    PubMed         Abstract available

    Leuk Res

  19. ODUTOLA PO, Olorunyomi PO, Olorunyomi I
    Single vs double umbilical cord blood transplantation in acute leukemia: Systematic review and meta-analysis.
    Leuk Res. 2024;142:107517.
    PubMed         Abstract available


  20. GALE RP, Hochhaus A
    To Mars and beyond. Space exploration and space medicine in Leukemia.
    Leukemia. 2024 May 22. doi: 10.1038/s41375-024-02286.

    Diagnostic and treatment strategies for pediatric acute lymphoblastic leukemia in low- and middle-income countries.
    Leukemia. 2024 May 18. doi: 10.1038/s41375-024-02277.
    PubMed         Abstract available

    Oncol Rep

  22. IDA N, Okura M, Tanaka S, Hosono N, et al
    Combining inotuzumab ozogamicin with PARP inhibitors olaparib and talazoparib exerts synergistic cytotoxicity in acute lymphoblastic leukemia by inhibiting DNA strand break repair.
    Oncol Rep. 2024;52:90.
    PubMed         Abstract available

    PLoS One

  23. HAN HJ, Choi K, Suh HS
    Impact of aging on acute myeloid leukemia epidemiology and survival outcomes: A real-world, population-based longitudinal cohort study.
    PLoS One. 2024;19:e0300637.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  24. WOLF KMP, Maffeis V, Schoenenberger CA, Zund T, et al
    Tweaking the NRF2 signaling cascade in human myelogenous leukemia cells by artificial nano-organelles.
    Proc Natl Acad Sci U S A. 2024;121:e2219470121.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.